Prevalence of Gastric and Duodenal Polyps and Risk Factors for Duodenal Neoplasm in Korean Patients with Familial Adenomatous Polyposis
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: The prevalence of gastric polyps, duodenal adenoma and duodenal cancer has been reported as being high among familial adenomatous polyposis (FAP)patients, but there have been no reports of this association in Korea. This study evaluated the prevalence of gastric and duodenal polyps and risk factors for duodenal neoplasm in FAP patients in Korea. Methods: We reviewed both initial and follow-up endoscopic results from FAP patients. We also investigated the treatment modality of duodenal adenomas and analyzed the risk factors of duodenal neoplasms by logistic regression analysis. Results: A total of 148 patients with FAP underwent esophagogastroduodenoscopy (EGD),and the fi ndings were as follows: gastric polyp 39.9% (fundic gland polyp 25.7% and gastric adenoma 14.2%), duodenal adenoma 15.5%, gastric cancer 2.7%, and duodenal cancer 0.7%. There were two cases of gastric cancer that developed from benign gastric polyps. There were progressions of duodenal adenomatosis during follow-up, and some degree of relapse occurred after endoscopic resection. Patients with gastric polyps showed a correlation with the occurrence of duodenal neoplasm (odds ratio, 2.814; p=0.024). Conclusions:In Korean FAP patients, gastric cancer was detected more frequently, but fundic gland polyps, duodenal adenoma and duodenal cancer were detected less frequently than in Western patients. FAP patients with gastric polyps should undergo regular EGD, particularly for the early detection of duodenal neoplasia.
Abstract
Background/Aims: The prevalence of gastric polyps, duodenal adenoma and duodenal cancer has been reported as being high among familial adenomatous polyposis (FAP)patients, but there have been no reports of this association in Korea. This study evaluated the prevalence of gastric and duodenal polyps and risk factors for duodenal neoplasm in FAP patients in Korea. Methods: We reviewed both initial and follow-up endoscopic results from FAP patients. We also investigated the treatment modality of duodenal adenomas and analyzed the risk factors of duodenal neoplasms by logistic regression analysis. Results: A total of 148 patients with FAP underwent esophagogastroduodenoscopy (EGD),and the fi ndings were as follows: gastric polyp 39.9% (fundic gland polyp 25.7% and gastric adenoma 14.2%), duodenal adenoma 15.5%, gastric cancer 2.7%, and duodenal cancer 0.7%. There were two cases of gastric cancer that developed from benign gastric polyps. There were progressions of duodenal adenomatosis during follow-up, and some degree of relapse occurred after endoscopic resection. Patients with gastric polyps showed a correlation with the occurrence of duodenal neoplasm (odds ratio, 2.814; p=0.024). Conclusions:In Korean FAP patients, gastric cancer was detected more frequently, but fundic gland polyps, duodenal adenoma and duodenal cancer were detected less frequently than in Western patients. FAP patients with gastric polyps should undergo regular EGD, particularly for the early detection of duodenal neoplasia.
참고문헌 (31)
- Järvinen H, "Upper gastrointestinal tract polyps in familial adenomatosis coli", Gut, 24, pp.333~339 (1983)
- Spigelman AD, "Evidence for adenomacarcinoma sequence in the duodenum of patients with familial adenomatous polyposis. The Leeds Castle Polyposis Group (Upper Gastrointestinal Committee)", J Clin Pathol, 47, pp.709~710 (1994)
- Gallagher MC, "Surveillance and management of upper gastrointestinal disease in familial adenomatous polyposis", Fam Cancer, 5, pp.263~273 (2006)
- Jagelman DG, "Upper gastrointestinal cancer in familial adenomatous polyposis", Lancet, 1, pp.1149~1151 (1988)
- Bülow S, "Results of national registration of familial adenomatous polyposis", Gut, 52, pp.742~746 (2003)
- Spigelman AD, "Upper gastrointestinal cancer in patients with familial adenomatous polyposis", Lancet, 2, pp.783~785 (1989)
- Zwick A, "Gastric adenocarcinoma and dysplasia in fundic gland polyps of a patient with attenuated adenomatous polyposis coli", Gastroenterology, 113, pp.659~663 (1997)
- Hofgärtner WT, "Gastric adenocarcinoma associated with fundic gland polyps in a patient with attenuated familial adenomatous polyposis", Am J Gastroenterol, 94, pp.2275~2281 (1999)
- Garrean S, "Gastric adenocarcinoma arising from fundic gland polyps in a patient with familial adenomatous polyposis syndrome", Am Surg, 74, pp.79~83 (2008)
- Sarre RG, "Gastric and duodenal polyps in familial adenomatous polyposis: a prospective study of the nature and prevalence of upper gastrointestinal polyps", Gut, 28, pp.306~314 (1987)
- Domizio P, "Upper gastrointestinal pathology in familial adenomatous polyposis: results from a prospective study of 102 patients", J Clin Pathol, 43, pp.738~743 (1990)
- Lepistö A, "Surveillance and treatment of duodenal adenomatosis in familial adenomatous polyposis", Endoscopy, 41, pp.504~509 (2009)
- Debinski HS, "Upper intestinal surveillance in familial adenomatous polyposis", Eur J Cancer, 31A, pp.1149~1153 (1995)
- Marcello PW, "Gastroduodenal polyps in familial adenomatous polyposis", Surg Endosc, 10, pp.418~421 (1996)
- Bülow S, "Duodenal adenomatosis in familial adenomatous polyposis", Gut, 53, pp.381~386 (2004)
- Offerhaus GJ, "The risk of upper gastrointestinal cancer in familial adenomatous polyposis", Gastroenterology, 102, pp.1980~1982 (1992)
- Park JG, "Risk of gastric cancer among Korean familial adenomatous polyposis patients. Report of three cases", Dis Colon Rectum, 35, pp.996~998 (1992)
- Odze RD, "Advanced gastroduodenal polyposis with ras mutations in a patient with familial adenomatous polyposis", Hum Pathol, 24, pp.442~448 (1993)
- Bianchi LK, "Fundic gland polyp dysplasia is common in familial adenomatous polyposis", Clin Gastroenterol Hepatol, 66, pp.180~185 (2008)
- Heiskanen I, "Management of duodenal adenomas in 98 patients with familial adenomatous polyposis", Endoscopy, 31, pp.412~416 (1999)
- Sexe RB, "Incidence and treatment of periampullary duodenal cancer in the U.S. veteran patient population", Cancer, 77, pp.251~254 (1996)
- Groves CJ, "Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study", Gut, 50, pp.636~641 (2002)
- Burke CA, "The natural history of untreated duodenal and ampullary adenomas in patients with familial adenomatous polyposis followed in an endoscopic surveillance program", Gastrointest Endosc, 49(3 Pt 1), pp.358~364 (1999)
- Brosens LA, "Prevention and management of duodenal polyps in familial adenomatous polyposis", Gut, 54, pp.1034~1043 (2005)
- Morpurgo E, "Clinical characteristics of familial adenomatous polyposis and management of duodenal adenomas", J Gastrointest Surg, 8, pp.559~564 (2004)
- Soravia C, "Management of advanced duodenal polyposis in familial adenomatous polyposis", J Gastrointest Surg, 1, pp.474~478 (1997)
- de Vos tot Nederveen Cappel WH, "Worldwide survey among polyposis registries of surgical management of severe duodenal adenomatosis in familial adenomatous polyposis", Br J Surg, 90, pp.705~710 (2003)
- Johnson MD, "Outcome based on management for duodenal adenomas: sporadic versus familial disease", J Gastrointest Surg, 14, pp.229~235 (2010)
- Ruo L, "Long-term follow-up of patients with familial adenomatous polyposis undergoing pancreaticoduodenal surgery", J Gastrointest Surg, 6, pp.671~675 (2002)
- Gallagher MC, "Pylorus-preserving pancreaticoduodenectomy for advanced duodenal disease in familial adenomatous polyposis", Br J Surg, 91, pp.1157~1164 (2004)
- Dekker E, "High resolution endoscopy and the additional value of chromoendoscopy in the evaluation of duodenal adenomatosis in patients with familial adenomatous polyposis", Endoscopy, 41, pp.666~669 (2009)